Full Text
HPR109 What Drives Socially Acceptable Costs in Outcomes Based Agreements? a Survey Studying Gene Therapies

Abstract

Authors

L. Van Der Lelie E. Yap J. Severens

Back to Volume 26, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×